Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Security class unavailable · CUSIP: 03168L105

Event date: 2018-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
13,983,650
Percent of class
12.1700%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-18-000529
Form type
SC 13G
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Nov 13, 2018
Reporting period
Oct 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub